Bio-Techne's Advanced Cell Diagnostics (ACD) sets new standa

Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD), a Bio-Techne spatial biology brand, has set a new standard with the development of a next-generation, protease-free RNAscope spatial multiomics workflow.

Related Keywords

Kim Kelderman , Bio Techne Corporation , From Bio Technejan , Techne Corporation , Advanced Cell Diagnostics , Chief Operating Officer , Lunaphore Suite , Genome Biology , Orlando Florida , Ge Ah Kim , Cell , Iagnostics , Multiomics , Maging , Amorphology , Protein , Na , Technology ,